Brain cancer breakthrough? stanford tests aggressive new combo therapy
NCT ID NCT04474353
Summary
This early-stage study tested the safety of combining three different treatments for newly diagnosed glioblastoma, a fast-growing brain cancer. It involved 12 adult patients who received a special electric field therapy, a short course of targeted radiation, and a chemotherapy drug. The main goal was to see if this intensive combination was safe and tolerable for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Stanford, California, 94304, United States
Conditions
Explore the condition pages connected to this study.